Related Experiment Video
Updated: Oct 15, 2025
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
1H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls
Albert Teis1, Esmeralda Castelblanco2, Germán Cediel3
1Institut del Cor, Departament de Cardiologia, Hospital Universitari Germans Trias, Badalona, Barcelona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
Insights
Patients with heart failure (HF) show distinct lipoprotein profiles, including lower high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle concentrations and larger particle sizes compared to controls. These differences highlight potential new avenues for understanding HF pathogenesis.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Biomarker Research
Background:
- Advanced lipoprotein phenotyping offers superior atherosclerotic cardiovascular risk prediction compared to cholesterol levels alone.
- Lipoprotein profiling in heart failure (HF) remains incompletely understood.
- Understanding these profiles is crucial for risk stratification and therapeutic development in HF patients.
Purpose of the Study:
- To characterize and compare the lipoprotein profile in patients with chronic heart failure (HF) against a matched control group.
- To investigate the relationship between lipoprotein characteristics and established cardiac biomarkers.
Main Methods:
- A cross-sectional study involving 429 ambulatory patients with chronic HF and 428 matched controls.
- Lipid concentrations and particle sizes of major lipoprotein fractions (HDL, LDL, VLDL) and their subfractions were measured using 1H magnetic resonance spectroscopy.
Main Results:
- Patients with chronic HF exhibited lower total cholesterol, LDL, and HDL particle concentrations compared to controls.
- A significantly lower concentration of small HDL subfractions was observed in HF patients.
- Mean VLDL, LDL, and HDL particle sizes were significantly larger in patients with HF.
- Cardiac biomarkers showed strong negative correlations with total and small LDL/HDL fractions and HDL particle size.
Conclusions:
- Significant differences in lipoprotein profiles exist between patients with chronic HF and unaffected controls.
- These distinct lipoprotein profiles may hold pathogenic relevance in HF.
- Further research is warranted to elucidate the clinical implications and pathogenic role of these lipoprotein alterations in heart failure.
Introduction And Objectives:
Advanced lipoprotein phenotyping is a better predictor of atherosclerotic cardiovascular risk than cholesterol concentration alone. Lipoprotein profiling in heart failure (HF) is incompletely characterized. We aimed to describe the lipoprotein profile in patients with chronic HF compared with a matched control population.
Methods:
This cross-sectional study was performed from May 2006 to April 2014 and included ambulatory patients with chronic HF. Lipid concentrations and the size of main lipoprotein fractions (high-density lipoprotein [HDL], low-density lipoprotein [LDL], and very low-density lipoprotein) and the particle concentration of their 3 subfractions (large, medium and small) were assessed using 1H magnetic resonance spectroscopy.
Results:
The 429 included patients with chronic HF were compared with 428 matched controls. Patients with chronic HF had lower total cholesterol and lower mean LDL (1115 vs 1352 nmol/L; P<.001) and HDL (25.7 vs 27.9μmol/L; P <.001) particle concentrations, with this last difference being mediated by a significantly lower concentration of the small subfraction of HDL (15.2 vs 18.6μmol/L; P <.001). Mean very low-density lipoprotein, LDL, and HDL particle size was significantly higher in patients with HF vs controls. All HDL-related differences from controls persisted after adjustment for New York Heart Association functional class or body mass index. We found strong negative correlations of known cardiac biomarkers (N-terminal pro-brain natriuretic peptide and interleukin-1 receptor-like 1) with total and small LDL and HDL fractions and HDL particle size.
Conclusions:
Patients with chronic HF significantly differ in their lipoprotein profile compared with unaffected controls. Further research is needed to better understand the pathogenic relevance of this difference.
More Related Videos
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:26Heart Failure III: Clinical Manifestations
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:17Pathophysiology of Heart Failure